Abbas, Baby Girl P.
HRN: 25-57-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2024
AMPICILLIN 250MG (VIAL)
07/31/2024
08/07/2024
IV
145 Mg
Q 12
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes